(Q37086291)

18 August 2017

1 reference

title

The importance of distant metastases in hormone-sensitive breast cancer (English)

1 reference

18 August 2017

1 reference

1

Hope S Rugo

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

17 Suppl 1

1 reference

18 August 2017

page(s)

S3-8

1 reference

Global cancer statistics, 2002

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Patterns of breast cancer relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Breast cancer metastasis to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Frequency of first metastatic events in breast cancer: implications for sequencing of systemic and local-regional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

Quality of life of breast cancer survivors after a recurrence: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2808%2970002-X

7 January 2021

10.1016/S0960-9776(08)70002-X

Identifiers

DOI

1 reference

18 August 2017

1 reference